This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Apr 8;137(14):1852-1853.

doi: 10.1182/blood.2021010688.

An ounce of which prevention is worth a…?

Joerg Halter¹, Jakob Passweg¹

Affiliations

PMID: 33830188
DOI: 10.1182/blood.2021010688

Free article

Comment

An ounce of which prevention is worth a…?

Joerg Halter et al. Blood. 2021.

Free article

. 2021 Apr 8;137(14):1852-1853.

doi: 10.1182/blood.2021010688.

Authors

Joerg Halter¹, Jakob Passweg¹

Affiliation

¹ Basel University Hospital.

PMID: 33830188
DOI: 10.1182/blood.2021010688

No abstract available

PubMed Disclaimer

Comment on

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Kennedy GA, Tey SK, Buizen L, Varelias A, Gartlan KH, Curley C, Olver SD, Chang K, Butler JP, Misra A, Subramoniapillai E, Morton AJ, Durrant S, Henden AS, Moore J, Ritchie D, Gottlieb D, Cooney J, Paul SK, Hill GR. Kennedy GA, et al. Blood. 2021 Apr 8;137(14):1970-1979. doi: 10.1182/blood.2020009050. Blood. 2021. PMID: 33512442 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations